Breaking News

BioDuro Opens New Peptide Laboratory in Shanghai

Enhancing its peptide synthesis capabilities to meet increasing demand from its global partners for efficient and scalable peptide manufacturing.

Author Image

By: Charlie Sternberg

Associate Editor

BioDuro, a Contract Research, Development, and Manufacturing Organization (CRDMO), has opened a fully-automated solid-phase peptide synthesis scale-up laboratory at its Shanghai Zhangjiang High-tech Park campus in China, further enhancing its peptide synthesis capabilities to meet increasing demand from its global partners for efficient and scalable peptide manufacturing. The kilogram-scale peptide laboratory is equipped with automated solid phase peptide synthesizers, cleavage systems and fr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters